Filing Details
- Accession Number:
- 0001628280-25-029370
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-06-04 16:41:37
- Reporting Period:
- 2025-06-03
- Filing Date:
- 2025-06-04
- Accepted Time:
- 2025-06-04 16:41:37
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1104506 | Insmed Inc | INSM | Pharmaceutical Preparations (2834) | 541972729 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1219023 | J W David Mcgirr | 700 Us Highway 202/206 Bridgewater NJ 08807 | Yes | No | No | No |
Transaction Summary
Sold: | 6,250 shares | Avg. Price: $72.25 | Total Value: $451,535.00 |
Number of Shares After Transactions: | 97,723 shares |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2025-06-03 | 3,250 | $71.30 | 100,723 | No | 4 | S | Direct | |
Common Stock | Disposition | 2025-06-04 | 3,000 | $73.27 | 97,723 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 4, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
- This is the weighted average sales price representing 3,250 shares sold at prices ranging from $71.09 to $71.54 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
- This is the weighted average sales price representing 3,000 shares sold at prices ranging from $73.13 to $73.41 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.